<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34043195</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>08</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>08</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1940-6029</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>2322</Volume>
            <PubDate>
              <Year>2021</Year>
            </PubDate>
          </JournalIssue>
          <Title>Methods in molecular biology (Clifton, N.J.)</Title>
          <ISOAbbreviation>Methods Mol Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Monitoring PINK1-Parkin Signaling Using Dopaminergic Neurons from iPS Cells.</ArticleTitle>
        <Pagination>
          <StartPage>81</StartPage>
          <EndPage>92</EndPage>
          <MedlinePgn>81-92</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/978-1-0716-1495-2_9</ELocationID>
        <Abstract>
          <AbstractText>The physiological importance of mitochondrial quality control has been uncovered by the finding that genes for early onset Parkinson's disease (PD), PINK1 and Parkin, regulate mitochondrial autophagy, called mitophagy, and motility. Dopaminergic neurons derived from human-induced pluripotent stem (iPS) cells are a useful tool for analyzing the pathogenesis caused by defects in mitochondrial quality control and for screening candidate drugs for PD. Moreover, dopaminergic neurons could provide new findings not obtained in other cells. In this chapter, we will describe our method for monitoring PINK1-Parkin signaling using iPS cell-derived dopaminergic neurons.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Shiba-Fukushima</LastName>
            <ForeName>Kahori</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurodegenerative and Demented Disorders, Juntendo University Graduate School of Medicine, Tokyo, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Imai</LastName>
            <ForeName>Yuzuru</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Research for Parkinson's Disease, Juntendo University Graduate School of Medicine, Tokyo, Japan. yzimai@juntendo.ac.jp.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan. yzimai@juntendo.ac.jp.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Methods Mol Biol</MedlineTA>
        <NlmUniqueID>9214969</NlmUniqueID>
        <ISSNLinking>1064-3745</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 2.3.2.27</RegistryNumber>
          <NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.3.2.27</RegistryNumber>
          <NameOfSubstance UI="C111567">parkin protein</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.-</RegistryNumber>
          <NameOfSubstance UI="D011494">Protein Kinases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.1</RegistryNumber>
          <NameOfSubstance UI="C433927">PTEN-induced putative kinase</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059290" MajorTopicYN="N">Dopaminergic Neurons</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D063306" MajorTopicYN="N">Mitophagy</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011494" MajorTopicYN="N">Protein Kinases</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D044767" MajorTopicYN="N">Ubiquitin-Protein Ligases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Autophagy</Keyword>
        <Keyword MajorTopicYN="Y">Dopaminergic neuron</Keyword>
        <Keyword MajorTopicYN="Y">Immunocytochemistry</Keyword>
        <Keyword MajorTopicYN="Y">Mitochondria</Keyword>
        <Keyword MajorTopicYN="Y">PINK1</Keyword>
        <Keyword MajorTopicYN="Y">Parkin</Keyword>
        <Keyword MajorTopicYN="Y">Ubiquitin</Keyword>
        <Keyword MajorTopicYN="Y">Western blot</Keyword>
        <Keyword MajorTopicYN="Y">iPS cells</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>27</Day>
          <Hour>12</Hour>
          <Minute>41</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34043195</ArticleId>
        <ArticleId IdType="doi">10.1007/978-1-0716-1495-2_9</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392(6676):605–608. https://doi.org/10.1038/33416</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/33416</ArticleId>
            <ArticleId IdType="pubmed">9560156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonzalez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304(5674):1158–1160. https://doi.org/10.1126/science.1096284</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1096284</ArticleId>
            <ArticleId IdType="pubmed">15087508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol JH, Yoo SJ, Hay BA, Guo M (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441(7097):1162–1166. https://doi.org/10.1038/nature04779</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature04779</ArticleId>
            <ArticleId IdType="pubmed">16672981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park J, Lee SB, Lee S, Kim Y, Song S, Kim S, Bae E, Kim J, Shong M, Kim JM, Chung J (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441(7097):1157–1161. https://doi.org/10.1038/nature04788</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature04788</ArticleId>
            <ArticleId IdType="pubmed">16672980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Y, Gehrke S, Imai Y, Huang Z, Ouyang Y, Wang JW, Yang L, Beal MF, Vogel H, Lu B (2006) Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci U S A 103(28):10793–10798. https://doi.org/10.1073/pnas.0602493103</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0602493103</ArticleId>
            <ArticleId IdType="pubmed">16818890</ArticleId>
            <ArticleId IdType="pmc">1502310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, Cookson MR, Youle RJ (2010) PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8(1):e1000298. https://doi.org/10.1371/journal.pbio.1000298</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pbio.1000298</ArticleId>
            <ArticleId IdType="pubmed">20126261</ArticleId>
            <ArticleId IdType="pmc">2811155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuda N, Sato S, Shiba K, Okatsu K, Saisho K, Gautier CA, Sou YS, Saiki S, Kawajiri S, Sato F, Kimura M, Komatsu M, Hattori N, Tanaka K (2010) PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol 189(2):211–221. https://doi.org/10.1083/jcb.200910140</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.200910140</ArticleId>
            <ArticleId IdType="pubmed">20404107</ArticleId>
            <ArticleId IdType="pmc">2856912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pickrell AM, Huang CH, Kennedy SR, Ordureau A, Sideris DP, Hoekstra JG, Harper JW, Youle RJ (2015) Endogenous Parkin preserves dopaminergic substantia nigral neurons following mitochondrial DNA mutagenic stress. Neuron 87(2):371–381. https://doi.org/10.1016/j.neuron.2015.06.034</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2015.06.034</ArticleId>
            <ArticleId IdType="pubmed">26182419</ArticleId>
            <ArticleId IdType="pmc">4803114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pimenta de Castro I, Costa AC, Lam D, Tufi R, Fedele V, Moisoi N, Dinsdale D, Deas E, Loh SH, Martins LM (2012) Genetic analysis of mitochondrial protein misfolding in Drosophila melanogaster. Cell Death Differ 19(8):1308–1316. https://doi.org/10.1038/cdd.2012.5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cdd.2012.5</ArticleId>
            <ArticleId IdType="pubmed">22301916</ArticleId>
            <ArticleId IdType="pmc">3392634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu S, Sawada T, Lee S, Yu W, Silverio G, Alapatt P, Millan I, Shen A, Saxton W, Kanao T, Takahashi R, Hattori N, Imai Y, Lu B (2012) Parkinson’s disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria. PLoS Genet 8(3):e1002537. https://doi.org/10.1371/journal.pgen.1002537</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pgen.1002537</ArticleId>
            <ArticleId IdType="pubmed">22396657</ArticleId>
            <ArticleId IdType="pmc">3291531</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X, Winter D, Ashrafi G, Schlehe J, Wong YL, Selkoe D, Rice S, Steen J, LaVoie MJ, Schwarz TL (2011) PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147(4):893–906. https://doi.org/10.1016/j.cell.2011.10.018</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2011.10.018</ArticleId>
            <ArticleId IdType="pubmed">22078885</ArticleId>
            <ArticleId IdType="pmc">3261796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jin SM, Lazarou M, Wang C, Kane LA, Narendra DP, Youle RJ (2010) Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J Cell Biol 191(5):933–942. https://doi.org/10.1083/jcb.201008084</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.201008084</ArticleId>
            <ArticleId IdType="pubmed">21115803</ArticleId>
            <ArticleId IdType="pmc">2995166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Okatsu K, Kimura M, Oka T, Tanaka K, Matsuda N (2015) Unconventional PINK1 localization to the outer membrane of depolarized mitochondria drives Parkin recruitment. J Cell Sci 128(5):964–978. https://doi.org/10.1242/jcs.161000</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.161000</ArticleId>
            <ArticleId IdType="pubmed">25609704</ArticleId>
            <ArticleId IdType="pmc">4342580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kondapalli C, Kazlauskaite A, Zhang N, Woodroof HI, Campbell DG, Gourlay R, Burchell L, Walden H, Macartney TJ, Deak M, Knebel A, Alessi DR, Muqit MM (2012) PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating serine 65. Open Biol 2(5):120080. https://doi.org/10.1098/rsob.120080</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1098/rsob.120080</ArticleId>
            <ArticleId IdType="pubmed">22724072</ArticleId>
            <ArticleId IdType="pmc">3376738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shiba-Fukushima K, Imai Y, Yoshida S, Ishihama Y, Kanao T, Sato S, Hattori N (2012) PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy. Sci Rep 2:1002. https://doi.org/10.1038/srep01002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep01002</ArticleId>
            <ArticleId IdType="pubmed">23256036</ArticleId>
            <ArticleId IdType="pmc">3525937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koyano K, Okatsu K, Kosako H, Tamura Y, Go E, Kimura M, Kimura Y, Tsuchiya H, Yoshihara H, Hirokawa T, Endo T, Fon E, Trempe J-F, Saeki Y, Tanaka K, Matsuda N (2014) Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 510(7503):162–166. https://doi.org/10.1038/nature13392</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature13392</ArticleId>
            <ArticleId IdType="pubmed">24784582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kane LA, Lazarou M, Fogel AI, Li Y, Yamano K, Sarraf SA, Banerjee S, Youle RJ (2014) PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J Cell Biol 205(2):143–153. https://doi.org/10.1083/jcb.201402104</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.201402104</ArticleId>
            <ArticleId IdType="pubmed">24751536</ArticleId>
            <ArticleId IdType="pmc">4003245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ordureau A, Sarraf SA, Duda DM, Heo JM, Jedrychowski MP, Sviderskiy VO, Olszewski JL, Koerber JT, Xie T, Beausoleil SA, Wells JA, Gygi SP, Schulman BA, Harper JW (2014) Quantitative proteomics reveal a feedforward mechanism for mitochondrial PARKIN translocation and ubiquitin chain synthesis. Mol Cell 56(3):360–375. https://doi.org/10.1016/j.molcel.2014.09.007</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molcel.2014.09.007</ArticleId>
            <ArticleId IdType="pubmed">25284222</ArticleId>
            <ArticleId IdType="pmc">4254048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shiba-Fukushima K, Arano T, Matsumoto G, Inoshita T, Yoshida S, Ishihama Y, Ryu KY, Nukina N, Hattori N, Imai Y (2014) Phosphorylation of mitochondrial polyubiquitin by PINK1 promotes Parkin mitochondrial tethering. PLoS Genet 10(12):e1004861. https://doi.org/10.1371/journal.pgen.1004861</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pgen.1004861</ArticleId>
            <ArticleId IdType="pubmed">25474007</ArticleId>
            <ArticleId IdType="pmc">4256268</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tanaka A, Cleland MM, Xu S, Narendra DP, Suen DF, Karbowski M, Youle RJ (2010) Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J Cell Biol 191(7):1367–1380. https://doi.org/10.1083/jcb.201007013</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.201007013</ArticleId>
            <ArticleId IdType="pubmed">21173115</ArticleId>
            <ArticleId IdType="pmc">3010068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lazarou M, Sliter DA, Kane LA, Sarraf SA, Wang C, Burman JL, Sideris DP, Fogel AI, Youle RJ (2015) The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524(7565):309–314. https://doi.org/10.1038/nature14893</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature14893</ArticleId>
            <ArticleId IdType="pubmed">26266977</ArticleId>
            <ArticleId IdType="pmc">5018156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Imaizumi Y, Okada Y, Akamatsu W, Koike M, Kuzumaki N, Hayakawa H, Nihira T, Kobayashi T, Ohyama M, Sato S, Takanashi M, Funayama M, Hirayama A, Soga T, Hishiki T, Suematsu M, Yagi T, Ito D, Kosakai A, Hayashi K, Shouji M, Nakanishi A, Suzuki N, Mizuno Y, Mizushima N, Amagai M, Uchiyama Y, Mochizuki H, Hattori N, Okano H (2012) Mitochondrial dysfunction associated with increased oxidative stress and alpha-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue. Mol Brain 5:35. https://doi.org/10.1186/1756-6606-5-35</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1756-6606-5-35</ArticleId>
            <ArticleId IdType="pubmed">23039195</ArticleId>
            <ArticleId IdType="pmc">3546866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shiba-Fukushima K, Ishikawa KI, Inoshita T, Izawa N, Takanashi M, Sato S, Onodera O, Akamatsu W, Okano H, Imai Y, Hattori N (2017) Evidence that phosphorylated ubiquitin signaling is involved in the etiology of Parkinson’s disease. Hum Mol Genet 26(16):3172–3185. https://doi.org/10.1093/hmg/ddx201</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddx201</ArticleId>
            <ArticleId IdType="pubmed">28541509</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamaguchi A, Ishikawa KI, Inoshita T, Shiba-Fukushima K, Saiki S, Hatano T, Mori A, Oji Y, Okuzumi A, Li Y, Funayama M, Imai Y, Hattori N, Akamatsu W (2020) Identifying therapeutic agents for amelioration of mitochondrial clearance disorder in neurons of familial Parkinson disease. Stem Cell Reports 14(6):1060–1075. https://doi.org/10.1016/j.stemcr.2020.04.011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.stemcr.2020.04.011</ArticleId>
            <ArticleId IdType="pubmed">32470327</ArticleId>
            <ArticleId IdType="pmc">7355139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shiba-Fukushima K, Inoshita T, Sano O, Iwata H, Ishikawa KI, Okano H, Akamatsu W, Imai Y, Hattori N (2020) A cell-based high-throughput screening identified two compounds that enhance PINK1-Parkin signaling. iScience 23(5):101048. https://doi.org/10.1016/j.isci.2020.101048</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.isci.2020.101048</ArticleId>
            <ArticleId IdType="pubmed">32335362</ArticleId>
            <ArticleId IdType="pmc">7183160</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
